GR60341B - A substained release pharmaceutical tablet - Google Patents

A substained release pharmaceutical tablet

Info

Publication number
GR60341B
GR60341B GR50306A GR760150306A GR60341B GR 60341 B GR60341 B GR 60341B GR 50306 A GR50306 A GR 50306A GR 760150306 A GR760150306 A GR 760150306A GR 60341 B GR60341 B GR 60341B
Authority
GR
Greece
Prior art keywords
release pharmaceutical
pharmaceutical tablet
substained release
substained
tablet
Prior art date
Application number
GR50306A
Other languages
Greek (el)
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of GR60341B publication Critical patent/GR60341B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR50306A 1975-03-17 1976-03-15 A substained release pharmaceutical tablet GR60341B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (1)

Publication Number Publication Date
GR60341B true GR60341B (en) 1978-05-17

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
GR50306A GR60341B (en) 1975-03-17 1976-03-15 A substained release pharmaceutical tablet

Country Status (21)

Country Link
JP (1) JPS51115910A (en:Method)
AR (1) AR222624A1 (en:Method)
AT (1) AT353415B (en:Method)
AU (1) AU505355B2 (en:Method)
CA (1) CA1073358A (en:Method)
CH (1) CH630257A5 (en:Method)
DD (1) DD124102A5 (en:Method)
DE (1) DE2611041A1 (en:Method)
DK (1) DK148344C (en:Method)
ES (1) ES446075A1 (en:Method)
FR (1) FR2304354A1 (en:Method)
GB (1) GB1546448A (en:Method)
GR (1) GR60341B (en:Method)
IE (1) IE43083B1 (en:Method)
LU (1) LU74558A1 (en:Method)
MC (1) MC1101A1 (en:Method)
NL (1) NL190313C (en:Method)
NZ (1) NZ180321A (en:Method)
PH (1) PH14927A (en:Method)
PT (1) PT64907B (en:Method)
SE (1) SE433804B (en:Method)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
DE69207656T2 (de) * 1991-01-30 1996-10-17 The Wellcome Foundation Ltd., London Wasserlösliche tabletten
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
EP0580861B1 (en) * 1991-04-08 1998-09-09 Nippon Shinyaku Company, Limited Sustained release capsule for adhesion in the gastrointestinal tract
JPH07507059A (ja) * 1992-03-25 1995-08-03 デポムド　システムズ，インコーポレイテッド アルキル置換セルロースをベースとする持続放出性経口薬剤投与剤形
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
ES2144532T3 (es) * 1993-10-29 2000-06-16 Scherer Corp R P Relleno de capsula de gelatina que puede formar espuma.
JPH09504286A (ja) * 1993-10-29 1997-04-28 レキット アンド コールマン プロダクツ リミテッド 発泡しうるゼラチンカプセル充填物
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
NZ287277A (en) * 1994-05-13 1998-05-27 Smithkline Beecham Corp Oral preparation containing calcium source within a hydrophilic polymer matrix for increasing calcium absorption in the stomach
CN1172429A (zh) * 1994-12-01 1998-02-04 希博斯药物公司 使用从高等植物中可得到的粉末状水解胶体树胶的持续释放药物运送体系
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (en:Method) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
LU74558A1 (en:Method) 1977-09-27
IE43083L (en) 1976-09-17
DD124102A5 (en:Method) 1977-02-02
NL7602776A (nl) 1976-09-21
JPS51115910A (en) 1976-10-13
AT353415B (de) 1979-11-12
PH14927A (en) 1982-01-29
AU1204976A (en) 1977-09-22
AU505355B2 (en) 1979-11-15
PT64907B (fr) 1978-03-24
DK148344C (da) 1985-11-04
PT64907A (fr) 1976-04-01
DE2611041C2 (en:Method) 1988-06-09
IE43083B1 (en) 1980-12-17
DK148344B (da) 1985-06-17
GB1546448A (en) 1979-05-23
DE2611041A1 (de) 1976-10-14
CA1073358A (en) 1980-03-11
DK113676A (da) 1976-09-18
ATA192276A (de) 1979-04-15
JPS638084B2 (en:Method) 1988-02-19
NZ180321A (en) 1978-06-20
NL190313C (nl) 1994-01-17
MC1101A1 (fr) 1977-02-04
CH630257A5 (en) 1982-06-15
ES446075A1 (es) 1977-09-16
FR2304354A1 (fr) 1976-10-15
SE433804B (sv) 1984-06-18
NL190313B (nl) 1993-08-16
SE7603325L (sv) 1976-09-18
FR2304354B1 (en:Method) 1979-04-27
AR222624A1 (es) 1981-06-15

Similar Documents

Publication Publication Date Title
GR60341B (en) A substained release pharmaceutical tablet
PT65863A (en) Capsules
JPS5210031A (en) Tablet system
GB2033353B (en) Tablet dispensers
IL51096A0 (en) Novel pharmaceutical dosage form
CS154076A2 (en) Zpusob kovani klik klikovych hridelu a zarizeni k provadeni tohoto zpusobu
JPS51147915A (en) Tablet system
ZA765931B (en) Controlled release tablet
AU504182B2 (en) Pharmaceutical dosage forms
JPS5244228A (en) Antigenic medicine
GB1552464A (en) Clutch-brake drive-steering mechanisms
GB1549171A (en) Pharmaceutical formulations containing hydrocy bezophenonederivatives
IL49681A0 (en) New eburnamenine derivatives and a process for the preparation thereof
GR61724B (en) Prolonged release pharmaceutical preparations
GB1555009A (en) Cluctch release mechanisms
AU1306576A (en) Pharmaceutical formulation
GB1533453A (en) Epoxy-androstanes and a process for the preparation thereof
ZA76829B (en) Tablet formulation
ZA767193B (en) Pharmaceutical antifertility-combinations
JPS5239494A (en) Device for grouping tablets* drops* etc*
IL47592A0 (en) Controlled drug releasing preparation
JPS5257315A (en) Tablet for medical preparation
JPS5283919A (en) Pharmaceutical tablet
ZA7627B (en) Pharmaceutical combination preparations
IL48550A (en) Tablet dispenser